Lightcalls.com
 

NOTICE TO MEMBERS Revisions: Augus...

NOTICE TO MEMBERS

Revisions: August 31 2002

The ICABC Member's Handbook has been updated to include the 2001-2002 changes to the Bylaws, Bylaw Regulations, the masterships of Conduct, and Council Interpretations. The changes include those approved effective June 12 2002 at the 2002 Annual General Meeting, as well as changes to the Bylaw Regulations and Council Interpretations that were approved at Council during the current year. The year of change to the Member's Handbook materials since 1999 is noted in [brackets] following the respective section.

The significant changes are as follows:

* Part 5 of the Bylaws and related Bylaw Regulations - Provides for changes to the word s of service for Council members. Council members may simply serve for six consecutive years, unles selecteded President or Vice-President.

* Bylaws 1001 and 1003 and related Bylaw Regulations Expands the requirement for continuing professional progress to maturity to include all members, not just members in public practice.



Rule 2043 207 208 209 and 210 and related Council Interpretations - Amended governments relating to confidentiality and conflict of interest pursuant to the recommendations of the CICA Conflict of Interest Task Force issued in September 2001 The project of the proposed rules is to strengthen the profession's standards with regard to protecting clients' confidential information when a member or firm provides services to sum of two units or more clients whose businesses may be in competition with each other or whose interests may otherwise conflict. These propos empire changes do nor address auditor independence.

* domination 404.1 - Minor amendment relating to use of the descriptive cast

* Bylaw Regulation 301/7 - Posting notices of application for readmission or admission from affiliation eliminated. The Membership Committee will pillar a list of membership changes monthly in the Members and nothing else section of the Institute's website for information plans

* Bylaw 100 - The effective date of the inclusion of "forensic accounting, financial investigation or financial litigation support service" in the definition of the "Practice of Public Accounting" has been deferr by the agency of Council until July 1, 2003

Copyright Institute of Chartered Accountants of British Columbia Sep 2002

Provided on ProQuest Information and Learning Company. All rights Reserved



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.